Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2014-06-22 Legal Proceedings Report
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Litigation update - orders on interest and costs 1
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement dated 23 June 2014 providing an update on litigation claims against former officers of the company. It details court judgments regarding interest, costs, and recovery of judgment debt. There is no financial data, no report attached or referenced as being published, and the content focuses solely on legal proceedings. Therefore, this document fits the category of Legal Proceedings Report (LTR). The document length is short and it is not a report publication announcement or certification. Hence, the classification is LTR with high confidence.
2014-06-22 English
Interview with Prof Bond and Dr Glass - webcast 1 p
Regulatory Filings Classification · 95% confidence The document is an ASX media announcement dated 18 June 2014, inviting investors to view a webcast interview discussing the science behind a drug candidate INV102 (nadolol). It contains no financial data, no regulatory filings, no voting results, no management changes, no earnings or annual report content. It is a promotional and informational announcement about a webcast and the company's drug development focus. The document length is 3056 characters, which is short and does not contain substantive financial or regulatory report content. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2014-06-17 English
Change to CEO remuneration 1 page 213.4KB
Remuneration Information Classification · 95% confidence The document is an ASX announcement dated 16 June 2014 regarding a change in CEO remuneration, specifically an increase in the base salary of the Managing Director and CEO. It references compliance with ASX Listing Rule 3.16.4 and details the salary change effective from 6 May 2014. The content is focused on executive compensation changes rather than a full remuneration report or proxy statement. Given the nature of the announcement about executive pay changes, it fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors. The document is short and specific to remuneration changes, not a full report or proxy solicitation.
2014-06-15 English
Investor presentation - Professor Bond briefings 33 pages 1.8MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation June | 2014' and contains detailed information about Invion Limited's drug candidates, clinical trials, scientific background, and development programs. It includes forward-looking statements, clinical trial designs, collaboration details, and market opportunities. The content is structured as a presentation aimed at investors, focusing on financial and strategic information rather than a formal regulatory filing or financial report. There is no indication that this is an annual report, earnings release, or regulatory filing. The length (15,000 characters) and detailed content support that this is a full investor presentation document rather than a brief announcement or summary. Therefore, the document best fits the category of Investor Presentation (IP).
2014-06-05 English
Investor briefings - Prof R Bond and Dr M Glass 1 p
Investor Presentation Classification · 90% confidence The document is an ASX media announcement dated 6 June 2014 about Invion Limited hosting investor briefings featuring presentations by experts and company executives. It describes the content and purpose of the briefings, focusing on scientific and development strategy insights. There is no detailed financial data, no full report, no voting results, no regulatory filings, or legal proceedings. The document is a communication aimed at investors providing information about upcoming presentations and company strategy, which fits the definition of an Investor Presentation announcement rather than the presentation itself. The document length is 3589 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the best classification is Investor Presentation (IP).
2014-06-05 English
Litigation update - Receipt of judgment 1 page 230.
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement dated 4 June 2014 regarding a litigation update on claims against former officers of the company. It details a court judgment requiring repayment of termination payments and dismissal of a counterclaim. The content focuses on legal proceedings and court decisions rather than financial results, management changes, or shareholder votes. The document length is short (1750 characters) and it is clearly an update on legal matters. Therefore, it fits best under the category of Legal Proceedings Report (LTR).
2014-06-03 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.